Low Plasma Lycopene Concentration is Associated with Increased Mortality in a Cohort of Patients with Prior Oral, Pharynx or Larynx Cancers
Susan T. Mayne, PhD,
Brenda Cartmel, PhD,
Haiqun Lin, MD, PhD,
Tongzhang Zheng, BMed, ScD, ScM and
W. Jarrard Goodwin, Jr, MD
Dept. of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT (S.T.M., B.C., H.L., T.Z.)
University of Miami, Miami, FL (W.J.G.)
View larger version (14K):
[in a new window]
|
Fig. 1. Kaplan Meier plot showing cumulative probability of survival by plasma lycopene concentration in all study participants at baseline. Dotted line shows above the median plasma lycopene concentration [>280 µg/L (>0.492 µmol/L)] while solid line shows below the median plasma lycopene concentrations. The two curves are significantly different (p = 0.006 log-rank test).
|
|
View larger version (13K):
[in a new window]
|
Fig. 2. Kaplan Meier plot showing cumulative probability of survival by plasma lycopene concentration in placebo group only at baseline. Dotted line shows above the median plasma lycopene concentration [>280 µg/L (>0.492 µmol/L)] while solid line shows below the median plasma lycopene concentrations. The two curves are significantly different (p = 0.037 log-rank test).
|
|
Copyright © 2004 by the American College of Nutrition.
